AAMRNet Calls for New Pilot Fund for Antimicrobials

With antimicrobial resistance (AMR) widely acknowledged as one of the biggest threats to global health, a new position statement from the Australian Antimicrobial Resistance Network (AAMRNet) highlights innovative strategies for bringing new antibiotic treatments to market.
Established by MTPConnect in 2020, AAMRNet is an Australian-first network bringing together industry, clinicians and researchers to address the impact of AMR on human health.

AAMRNet and respective member organisations have developed the position statement to guide the way in which pricing and funding of novel antimicrobials in Australia is undertaken.

AAMRNet co-chair and MTPConnect CEO Stuart Dignam says the position statement is aimed at stimulating discussion and spurring action.